All content for The Certara Market Access Channel is the property of Certara Evidence & Access and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the Market Access Podcast, your expert briefing on the latest in Market Access and Health Economics in the Bio-Pharmaceutical Industries.
In our first episode, we're shining a light on the next frontier for outcomes-based agreements (OBA). If we move beyond the initial excitement and PR, where does pharma stand on risk-sharing and innovative contracting?
Experts
Roman Casciano, GM, Analytica Laser & SVP, Market Access, HEOR and Real-world Evidence, Certara
Lee Stern, VP, Business Development, Certara Evidence & Access
Ulrich Neumann, Sr. Director, Head US Access, Certara (ulrich.neumann@certara.com)
The Certara Market Access Channel
Welcome to the Market Access Podcast, your expert briefing on the latest in Market Access and Health Economics in the Bio-Pharmaceutical Industries.
